We are live on ! Find out more
CINC

CinCor Pharma, Inc. Common Stock

Delisted

CINC was delisted on the 23rd of February, 2023.

53 hedge funds and large institutions have $520M invested in CinCor Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+53
Holders Change %
% of All Funds
0.84%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
53
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LP
26
LMR Partners
United Kingdom
$533K +$624K +30,402 New
Walleye Capital
27
Walleye Capital
New York
$496K +$580K +28,250 New
PHK
28
Point72 Hong Kong
Hong Kong
$387K +$453K +22,064 New
N
29
Nuveen
North Carolina
$284K +$332K +16,179 New
DKCM
30
Davidson Kempner Capital Management
New York
$262K +$308K +15,000 New
Goldman Sachs
31
Goldman Sachs
New York
$238K +$278K +13,562 New
Millennium Management
32
Millennium Management
New York
$210K +$246K +12,000 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$167K +$195K +9,500 New
Bank of America
34
Bank of America
North Carolina
$163K +$191K +9,302 New
MIM
35
MetLife Investment Management
New Jersey
$142K +$166K +8,090 New
Deutsche Bank
36
Deutsche Bank
Germany
$120K +$139K +6,794 New
AIG
37
American International Group
New York
$101K +$118K +5,761 New
JP Morgan Chase
38
JP Morgan Chase
New York
$95K +$112K +5,441 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$87K +$101K +4,936 New
Morgan Stanley
40
Morgan Stanley
New York
$53K +$62.4K +3,043 New
SO
41
STRS Ohio
Ohio
$47K +$55.4K +2,700 New
Wells Fargo
42
Wells Fargo
California
$44K +$51.9K +2,531 New
AB
43
Amalgamated Bank
New York
$40K +$46.6K +2,271 New
AF
44
Amalgamated Financial
New York
$40K +$46.6K +2,271 New
UBS Group
45
UBS Group
Switzerland
$38K +$44.2K +2,155 New
Barclays
46
Barclays
United Kingdom
$34K +$38.7K +1,884 New
CSS
47
Cubist Systematic Strategies
Connecticut
$32K +$36.9K +1,800 New
Legal & General Group
48
Legal & General Group
United Kingdom
$19K +$22.6K +1,103 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$18K +$20.8K +1,013 New
Citigroup
50
Citigroup
New York
$18K +$20.9K +1,020 New

CINC Hedge Fund Activity: Q1 2022 in Review

53 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CinCor Pharma, Inc. Common Stock (CINC) for Q1 2022, worth a combined $520M.

Buyers outnumbered sellers: 53 funds opened new CINC positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sofinnova Investments, opening a new position worth an estimated $114M.

  • 53 institutional investors held CinCor Pharma, Inc. Common Stock (CINC) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $520M of CinCor Pharma, Inc. Common Stock stock for Q1 2022.
  • 53 funds opened new CinCor Pharma, Inc. Common Stock positions in Q1 2022 and 0 closed out, a net change of +53 holders.
  • The largest CinCor Pharma, Inc. Common Stock buyer in Q1 2022 was Sofinnova Investments, an estimated $114M added.

Based on aggregated 13F filings for Q1 2022.